Expression of BRCA1 and BRCA2 proteins and their correlation with clinical staging in breast cancer

Journal of Cancer Research and Therapeutics

Volumn 11, Issue 1, 2015, Pages 158-163

  Hedau, Suresh ^a   Batra, Madhu ^b   Singh, Usha Rani ^b   Bharti, Alok C ^a   Ray, Amitabha ^c   Das, Bhudev C ^a  

^a INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

^b UCMS AND GTB HOSPITAL   (India)

^c SAINT JAMES SCHOOL OF MEDICINE   (Anguilla)

Author keywords

BRCA1 gene; BRCA2 gene; immunohistochemistry; sporadic breast cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PARAFFIN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POSTMENOPAUSE; PROTEIN EXPRESSION; TISSUE SECTION; BREAST TUMOR; CANCER GRADING; CELL TRANSFORMATION; GENE EXPRESSION; GENETICS; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; RISK FACTOR; YOUNG ADULT;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; RISK FACTORS; YOUNG ADULT;

EID: 84928624544     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.140985     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Murthy NS, Agarwal UK, Chaudhry K, Saxena S. A study on time trends in incidence of breast cancer: Indian scenario. Eur J Cancer Care (Engl) 2007;16:185-6.
3. Porter PL. Global trends in breast cancer incidence and mortality. Salud Publica Mex 2009;51 Suppl 2:s141-6.
4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
5. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
6. Smith SA, Easton DF, Evans DG, Ponder BA. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992;2:128-31.
7. de Juan Jiménez I, Esteban Cardeñosa E, Palanca Suela S, Barragán González E, Aznar Carretero I, Munárriz Gandía B, et al. Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population. Fam Cancer 2012;11:49-56.
8. Rhiem K, Todt U, Wappenschmidt B, Klein A, Wardelmann E, Schmutzler RK. Sporadic breast carcinomas with somatic BRCA1 gene deletions share genotype/phenotype features with familial breast carcinomas. Anticancer Res 2010;30:3445-9.
9. Irving M, Elmslie F, Berg J. 18. Genetics of breast cancer. Int J Clin Pract 2002;56:677-82.
10. Koumpis C, Dimitrakakis C, Antsaklis A, Royer R, Zhang S, Narod SA, et al. Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece. Hered Cancer Clin Pract 2011;9:10.
11. Musolino A, Bella MA, Bortesi B, Michiara M, Naldi N, Zanelli P, et al. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study. Breast 2007;16:280-92.
12. Rajan JV, Marquis ST, Gardner HP, Chodosh LA. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol 1997;184:385-401.
13. Rakha EA, El-Sheikh SE, Kandil MA, El-Sayed ME, Green AR, Ellis IO. Expression of BRCA1 protein in breast cancer and its prognostic significance. Hum Pathol 2008;39:857-65.
14. Dinesh KP, Devaraj H, Murugan V, Rajaraman R, Niranjali S. Analysis of loss of heterozygosity and immunohistochemistry in BRCA1 gene in sporadic breast cancer. Mol Cell Biochem 2006;287:177-83.
15. Miyamoto K, Fukutomi T, Asada K, Wakazono K, Tsuda H, Asahara T, et al. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers. Jpn J Clin Oncol 2002;32:79-84.
16. Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, Karnan S, et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proc Natl Acad Sci U S A 2011;108:17773-8.
17. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266:120-2.
18. Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, et al. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res Treat 2004;88:177-86.
19. Rajan JV, Wang M, Marquis ST, Chodosh LA. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci U S A 1996;93:13078-83.
20. Amirrad M, Al-Mulla F, Varadharaj G, John B, Saji T, Anim JT. BRCA1 gene expression in breast cancer in Kuwait: Correlation with prognostic parameters. Med Princ Pract 2005;14:67-72.
21. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinoma. Nat Genet 1999;21:236-40.
22. Yoshikawa K, Honda K, Inamoto T, Shinohara H, Yamauchi A, Suga K, et al. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1 associated cases. Clin Cancer Res 1999;5:1249-61.
23. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EI, Cooney KA, et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumors. Nat Genet 1995;9:439-43.
24. Xu J, Huo D, Chen Y, Nwachukwu C, Collins C, Rowell J, et al. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors. Breast Cancer Res Treat 2010;120:593-601.
25. Chodosh LA. Expression of BRCA1 and BRCA2 in normal and neoplastic cells. J Mammary Gland Biol Neoplasia 1998;3:389-402.
26. Jeffy BD, Schultz EU, Selmin O, Gudas JM, Bowden GT, Romagnolo D. Inhibition of BRCA1 expression by benzo[a] pyrene and its diolepoxide. Mol Carcinog 1999;26:100-18.
27. Bieche I, Nogues C, Lidereau R. Over expression of BRCA2 gene in sporadic breast tumours. Oncogene 1999;6:5232-8.
28. Collins N, Wooster R, Stratton MR. Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Br J Cancer 1997;76:1150-6.
29. Miki Y, Katagiri T, Kasumi F, Yoshimoto T, Nakamua Y. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat Genet 1996;13:245-7.
30. Brozek I, Ochman K, Debniak J, Morzuch L, Ratajska M, Stepnowska M, et al. Loss of heterozygosity at BRCA 1/2 loci in hereditary and sporadic ovarian cancers. J Appl Genet 2009;50:379-84.